Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma

Nat Commun. 2015 May 26:6:7213. doi: 10.1038/ncomms8213.

Abstract

Multiple myeloma (MM) is characterized by an uninhibited, clonal growth of plasma cells. While first-degree relatives of patients with MM show an increased risk of MM, the genetic basis of inherited MM susceptibility is incompletely understood. Here we report a genome-wide association study in the Nordic region identifying a novel MM risk locus at ELL2 (rs56219066T; odds ratio (OR)=1.25; P=9.6 × 10(-10)). This gene encodes a stoichiometrically limiting component of the super-elongation complex that drives secretory-specific immunoglobulin mRNA production and transcriptional regulation in plasma cells. We find that the MM risk allele harbours a Thr298Ala missense variant in an ELL2 domain required for transcription elongation. Consistent with a hypomorphic effect, we find that the MM risk allele also associates with reduced levels of immunoglobulin A (IgA) and G (IgG) in healthy subjects (P=8.6 × 10(-9) and P=6.4 × 10(-3), respectively) and, potentially, with an increased risk of bacterial meningitis (OR=1.30; P=0.0024).

Publication types

  • Meta-Analysis
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • Humans
  • Immunoglobulin A / blood*
  • Immunoglobulin G / blood*
  • Intracellular Signaling Peptides and Proteins
  • Meningitis, Bacterial / genetics
  • Multiple Myeloma / genetics*
  • Proteins / genetics*
  • Transcriptional Elongation Factors / genetics*

Substances

  • ELL2 protein, human
  • Immunoglobulin A
  • Immunoglobulin G
  • Intracellular Signaling Peptides and Proteins
  • Proteins
  • TOM1 protein, human
  • Transcriptional Elongation Factors